Integral Molecular · Since 2001

Integral Molecular

Built on innovation and driven to impact the scientific community and human health.

Integral Molecular applies deep expertise in target biology, antibody discovery, virology, and protein engineering to advance therapies against difficult-to-treat diseases. It is an experienced provider of pseudoviruses, virus-like particles, and other virology products.

Integral Molecular
Integral Molecular logo
Photo: Unsplash
About the Partner

More About Integral Molecular

The flagship product is Reporter Virus Particles (RVPs). These non-replicative particles are a safe, ready-to-use substitute for live virus. RVPs are ideal for infectivity and neutralization assays.

Rigorous specificity analysis is critical for successful drug development and a safety requirement for antibody-based therapies, such as CAR-T, entering IND. Integral Molecular has developed the Membrane Proteome Array (MPA) platform to de-risk antibody-based therapeutics by testing specificity across the full human membrane proteome expressed in live cells. Using sensitive high-throughput flow cytometry to identify binding interactions on a protein level, this technology has emerged as the leading solution for antibody specificity profiling.

Proven Quality

Its technologies continuously contribute to scientific discoveries featured in peer-reviewed publications, including in top journals.

Open Communication

Your success is the priority — working hard to understand your needs and striving to exceed your expectations.

Broad Virology Catalog

Supports scientists in the fight against influenza, SARS-CoV-2, dengue, Zika, Chikungunya, Ebola, Marburg, Nipah, and more.

More Than a Reagent

Every order comes with optimized protocols and technical support, backed by the highest quality standards and 20+ years of expertise.